# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)))) today announced the availability of QCI Secondary Analysis, a cloud-based...
Stifel analyst Daniel Arias maintains Qiagen (NYSE:QGEN) with a Hold and lowers the price target from $55 to $45.
Qiagen (NYSE:QGEN) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.44 by 4.55 pe...
U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events...
U.S. stocks are looking to build on past week’s gains, with the mood remaining cautiously optimistic. The major index futures w...
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...
QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)))) today announced the launch of the QIAseq xHYB Mycobacterium tuberculosis P...
QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)))) today announced a partnership with the International Panel Physicians Asso...